{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:32:09Z","timestamp":1792740729682,"version":"4.5.0"},"reference-count":21,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Diagn Lab Immunol"],"published-print":{"date-parts":[[2001,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Complement-mediated bactericidal antibodies in serum confer protection against meningococcal disease. The minimum protective titer is estimated to be between 1:4 and 1:8 when measured by the Goldschneider assay performed with human complement, the assay used in the 1960s to establish the correlation between bactericidal antibodies and protection. A more recently described bactericidal assay standardized by an international consortium uses rabbit complement, which is known to augment bactericidal titers. To define a protective titer measured by the standardized assay, we compared bactericidal titers against serogroup C strains measured by this assay to titers measured by the assay described by Goldschneider et al. A titer of \u22651:128 measured by the standardized assay was needed to predict with \u226580% certainty a positive titer of \u22651:4 as measured by the Goldschneider assay. However, the majority of samples with titers of 1:4 measured by the Goldschneider assay had titers of &lt;1:128 when measured by the standardized assay. Therefore, by the results of the standardized assay such persons would be falsely categorized as being susceptible to disease. In conclusion, high bactericidal titers measured with the standardized assay performed with rabbit complement are predictive of protection, but no threshold titer is both sensitive and specific for predicting a positive titer measured by the Goldschneider assay using human complement. Up to 10% of the U.S. adult population lacks intrinsic bactericidal activity against serogroup C strains in serum and can serve as complement donors. Therefore, use of the Goldschneider assay or an equivalent assay performed with human complement is preferred over assays that use rabbit complement.<\/jats:p>","DOI":"10.1128\/cdli.8.3.616-623.2001","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T09:56:57Z","timestamp":1027763817000},"page":"616-623","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":94,"title":["Importance of Complement Source in Measuring Meningococcal Bactericidal Titers"],"prefix":"10.1128","volume":"8","author":[{"given":"George F.","family":"Santos","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Chiron Corporation, Emeryville,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Randall","family":"Deck","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Chiron Corporation, Emeryville,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Donnelly","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Chiron Corporation, Emeryville,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Blackwelder","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Biologics Consulting Group, Alexandria, Virginia2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan M.","family":"Granoff","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Children's Hospital, Oakland Research Institute, Oakland,3California, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.3.1568-1573.2001"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00423-5"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.3109\/inf.1977.9.issue-2.09"},{"key":"e_1_3_2_5_2","unstructured":"Frasch C. E. Meningococcal vaccines: past present and future Meningococcal disease. Cartwright K. 1995 245 283 John Wiley & Sons New York N.Y"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.129.6.1307"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.129.6.1327"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1086\/515346"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.5.4.479-485.1998"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.4049\/jimmunol.130.6.2882","article-title":"IgA blocks IgM and IgG-initiated immune lysis by separate molecular mechanisms.","volume":"130","author":"Griffiss J. M.","year":"1983","unstructured":"Griffiss J. M. Goroff D. K. IgA blocks IgM and IgG-initiated immune lysis by separate molecular mechanisms. J. Immunol. 130 1983 2882 2885","journal-title":"J. Immunol."},{"key":"e_1_3_2_11_2","first-page":"147","article-title":"Bactericidal antibodies after vaccination with the Norwegian meningococcal serogroup B outer membrane vesicle vaccine: a brief survey.","volume":"14","author":"Hoiby E. A.","year":"1991","unstructured":"Hoiby E. A. Rosenqvist E. Froholm L. O. Bjune G. Feiring B. Nokleby H. Ronnild E. Bactericidal antibodies after vaccination with the Norwegian meningococcal serogroup B outer membrane vesicle vaccine: a brief survey. NIPH Ann. 14 1991 147 155","journal-title":"NIPH Ann."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1006\/biol.2000.0253"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.19.1685"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.21.2795"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/172.5.1279"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/cdli.4.2.156-167.1997"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.6.2453-2459.1998"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(96)00001-1"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.16.1520"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-1157(77)80005-X"},{"key":"e_1_3_2_21_2","first-page":"72","article-title":"Requirements for meningococcal polysaccharide vaccine (requirements for biological substances no. 23).","volume":"594","author":"World Health Organization","year":"1976","unstructured":"World Health Organization Requirements for meningococcal polysaccharide vaccine (requirements for biological substances no. 23). WHO Tech. Rep. Ser. 594 1976 72 73","journal-title":"WHO Tech. Rep. Ser."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.40.1.257-264.1983"}],"container-title":["Clinical Diagnostic Laboratory Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CDLI.8.3.616-623.2001","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CDLI.8.3.616-623.2001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T14:57:43Z","timestamp":1682261863000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CDLI.8.3.616-623.2001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["10.1128\/CDLI.8.3.616-623.2001"],"URL":"https:\/\/doi.org\/10.1128\/cdli.8.3.616-623.2001","relation":{},"ISSN":["1071-412X","1098-6588"],"issn-type":[{"value":"1071-412X","type":"print"},{"value":"1098-6588","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,5]]},"assertion":[{"value":"2000-10-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-03-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-05-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}